2004
DOI: 10.1016/j.jss.2004.06.016
|View full text |Cite
|
Sign up to set email alerts
|

Ergothioneine pretreatment protects the liver from ischemia-reperfusion injury caused by increasing hepatic heat shock protein 70

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
43
0

Year Published

2006
2006
2022
2022

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 55 publications
(45 citation statements)
references
References 22 publications
2
43
0
Order By: Relevance
“…In certain experiments, chronic treatment with ergothioneine (10-1000 mg/kg per day) was started on day 0. This dosage range of ergothioneine has been used in other studies and no toxicity was observed (Moncaster et al, 2002;Bedirli et al, 2004). In the rat, a steady blood concentration of 20 mg/ml (∼87 mM) is achieved when a single intravenous dose of 100 mg/kg ergothioneine is given (Kaneko et al, 1980).…”
Section: Methodsmentioning
confidence: 92%
See 2 more Smart Citations
“…In certain experiments, chronic treatment with ergothioneine (10-1000 mg/kg per day) was started on day 0. This dosage range of ergothioneine has been used in other studies and no toxicity was observed (Moncaster et al, 2002;Bedirli et al, 2004). In the rat, a steady blood concentration of 20 mg/ml (∼87 mM) is achieved when a single intravenous dose of 100 mg/kg ergothioneine is given (Kaneko et al, 1980).…”
Section: Methodsmentioning
confidence: 92%
“…liver by increasing heat shock proteins-70 and decreasing tumor necrosis factor-a, interleukin-1b, malondialdehyde, and myeloperoxidase levels in the tissues (Bedirli et al, 2004;Sakrak et al, 2008). Ergothioneine is obtained from diet and its concentration in human blood ranges from 11.9 to 13.5 mg/l (i.e., 51.9 to 58.9 mM) for normal subjects, 11.6 to 13.6 mg/l (i.e., 50.6 to 60.1 mM) for type I diabetic subjects, and 11.9 to 21.9 (i.e., 51.9 to 95.5 mM) for type II diabetic subjects (Epand et al, 1988).…”
Section: Ergothioneine Protects Endothelial Cellsmentioning
confidence: 99%
See 1 more Smart Citation
“…Dysfunction of the liver sinusoidal cells has been observed during arsenic-induced oxidative stress, leading to vascular disease atherosclerosis (States et al, 2009). Bedirli et al (2004) have demonstrated that exogenous administration of ERGO improves survival in animals with liver injury induced by ischemia and reperfusion. Thus, ERGO may function as one of the defense mechanisms acting under such pathological conditions.…”
Section: Discussionmentioning
confidence: 99%
“…The HO system is among the most critical of the cytoprotective mechanisms activated during cellular stress, hyperthermic preconditioning, or long-term fasting, exerting antioxidant and anti-inflammatory functions, acting as a molecular chaperon, modulating cell cycle, and maintaining microcirculation (3,9,20).…”
mentioning
confidence: 99%